Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors—Data From the ARON-1 Study Global Burden of Disease Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results